People In Brief
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences shuffle: Corinne Lyle moves from her role as CFO and treasurer into the newly created position of president-global operations, effective Jan. 1. Lyle joined Edwards in 2003 from pharmaceutical company Tularik, where she was CFO. She is succeeded at Edwards by Thomas Abate, who leaves his position as VP and controller. Abate joined Baxter in 1982; he played a key role in Edwards' spin-off from the firm, where he was controller of the cardiovascular group, in 2000...
You may also be interested in...
People In Brief
Orthofix names new CEO: Chief Operating Officer Alan Milinazzo will be promoted to the orthopedic firm's top spot effective April 1. He will replace Charles Federico, who will remain a director of Orthofix. The company has not yet named a successor to the COO position. Milinazzo joined Orthofix as its first-ever operations executive in September 2005 after three years at Medtronic, where he served as VP of its vascular, peripheral and coronary business units. He previously worked at Boston Scientific for 12 years in a variety of roles, including VP of marketing. In January, the firm hired a new general manager for their vascular business (1"The Gray Sheet" Jan. 2, 2006, p. 19)...
People In Brief
Orthofix names new CEO: Chief Operating Officer Alan Milinazzo will be promoted to the orthopedic firm's top spot effective April 1. He will replace Charles Federico, who will remain a director of Orthofix. The company has not yet named a successor to the COO position. Milinazzo joined Orthofix as its first-ever operations executive in September 2005 after three years at Medtronic, where he served as VP of its vascular, peripheral and coronary business units. He previously worked at Boston Scientific for 12 years in a variety of roles, including VP of marketing. In January, the firm hired a new general manager for their vascular business (1"The Gray Sheet" Jan. 2, 2006, p. 19)...
People In Brief
CoreValve gets reg affairs in order: Kalathi Thyagarajan, PhD, joins as VP-regulatory affairs & quality assurance. Thyagarajan, who has consulted for CoreValve since June, will be tasked with securing ISO certification of Irvine, Calif.-based CoreValve USA and managing the clinical trial for the ReValving percutaneous aortic valve system to support European regulatory approval. He is also responsible for interacting with FDA. Previously, Thyagarajan served in senior research and regulatory management roles at cardiac implant start-ups 3F Therapeutics and VenPro. He also worked at Edwards Lifesciences before its spin-off from Baxter in 2000. CoreValve recently said it may go public in 2007 (1"The Gray Sheet" Nov. 21, 2005, p. 17)...